إعلان
إعلان
IBIO
iBio, Inc. Common Stock
2.69
USDبرعاية
+0.34
+14.38%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
2.67
-0.02
-0.86%
تقارير أرباح IBIO
النسبة الإيجابية المفاجئة
IBIO تفوق 7 من 17 آخر التقديرات.
41%
التقرير التالي
بيانات التقرير القادم
٠٩ فبراير ٢٠٢٦
Estimate for Q2 26 (Revenue/ EPS)
$34.00K
/-$0.09
التغير الضمني من Q1 26 (Revenue/ EPS)
-66.00%
/-18.18%
التغير الضمني من Q2 25 (Revenue/ EPS)
-83.00%
/-81.25%
iBio, Inc. Common Stock earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, IBIO reported earnings of -0.11 USD per share (EPS) for Q1 26, missing the estimate of -0.10 USD, resulting in a -5.16% surprise. Revenue reached 100.00 ألف, compared to an expected 25.50 ألف, with a 292.16% difference. The market reacted with a -8.00% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 المحللين forecast an EPS of -0.09 USD, with revenue projected to reach 34.00 ألف USD, implying an نقصان of -18.18% EPS, and نقصان of -66.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were iBio, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, iBio, Inc. Common Stock reported EPS of -$0.11, missing estimates by -5.16%, and revenue of $100.00K, 292.16% above expectations.
How did the market react to iBio, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -8%, changed from $1.25 before the earnings release to $1.15 the day after.
When is iBio, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٩ فبراير ٢٠٢٦.
What are the forecasts for iBio, Inc. Common Stock's next earnings report?
Based on 6
المحللين, iBio, Inc. Common Stock is expected to report EPS of -$0.09 and revenue of $34.00K for Q2 2026.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان